/drug-combination-safety

Not medical advice. Speak with a healthcare professional before using any medication.


Feel confident about your treatment — learn what’s safe.
Contact UsWhether progesterone and melatonin may be used together depends on individual health factors, and a prescriber or pharmacist is best positioned to assess appropriateness for each patient. According to Lexicomp, no clinically significant pharmacokinetic interaction has been identified between oral progesterone and melatonin at typical doses.
Per FDA-approved labeling, oral micronized progesterone has a GABA-modulatory effect on the central nervous system, which may contribute to sedation. This is one reason oral progesterone is often prescribed at bedtime.
Melatonin works through a distinct mechanism. Per prescribing information for melatonin receptor agonists and published literature on exogenous melatonin, it acts primarily on MT1 and MT2 receptors to regulate circadian rhythm — functioning as a timing signal rather than a direct CNS depressant.
Because these agents act on separate receptor systems, according to Lexicomp, they are not generally expected to interact directly in most patients or to amplify each other in a clinically dangerous way. However, additive sedation is a theoretical concern, and individual responses vary.
Increased ease of sleep onset — progesterone's calming effect and melatonin's circadian signaling may act in a complementary way for some patients.
Possible next-day grogginess — some individuals may experience residual sedation, particularly at higher melatonin doses.
No established dangerous interaction at standard doses per Lexicomp, though clinical appropriateness depends on individual patient factors.
Patients who experience unusual next-morning grogginess, difficulty waking, or other unexpected symptoms should contact their prescriber. A dose review of either or both agents may be warranted. Individual factors including age, renal and hepatic function, and concomitant medications may affect tolerability.
A licensed prescriber should evaluate whether this combination is appropriate for each patient's clinical situation.
Compounded medications are not FDA-approved. A licensed prescriber should determine whether any compounded preparation is appropriate based on individual patient needs.
Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. FDA-approved medications should be considered first when commercially available options meet patient needs. Compounded preparations are prepared by licensed pharmacists in response to valid prescriptions for individual patients. Interaction and safety information on this page is based on FDA-approved formulations and may not fully apply to compounded preparations, which differ in formulation and regulatory status.
Common
Mild
Per FDA-approved labeling, oral micronized progesterone may cause somnolence. Melatonin and related receptor agonists are also associated with sedation per prescribing information. When used together, stronger nighttime sleepiness and residual grogginess the following morning are possible. Consult a clinician if symptoms persist or interfere with daily functioning.
Normally lasts for:
8–12 hours
Occasional
Mild
Per FDA-approved labeling, progesterone is associated with dizziness, particularly when used at bedtime doses. Additive CNS effects from melatonin may contribute to brief dizziness or reduced alertness, especially when standing up quickly. Consult a clinician if symptoms persist or worsen.
Normally lasts for:
0.5–2 hours
Occasional
Mild
Per FDA-approved labeling, progesterone therapy may be associated with mood-related effects including irritability or emotional lability in some patients. Some individuals notice mild mood shifts such as irritability, low mood, or emotional sensitivity during hormone adjustment. Consult a clinician if mood changes are persistent or distressing.
Normally lasts for:
2–6 hours
Occasional
Mild
Per FDA-approved labeling, headache is listed as an adverse effect for both progesterone and melatonin receptor agonists. Tension-type or dull headaches may occur, particularly when initiating therapy or at higher doses. Consult a clinician if headaches persist or are severe.
Normally lasts for:
1–4 hours
Common
Mild
Per prescribing information for melatonin receptor agonists, abnormal dreams are a recognized adverse effect. Progesterone's sleep-deepening properties may also influence dream intensity. Some patients report more vivid or memorable dreams when using these agents together. Consult a clinician if sleep quality is significantly affected.
Normally lasts for:
4–8 hours
Occasional
Mild
Per FDA-approved labeling, gastrointestinal effects including nausea and abdominal discomfort are recognized adverse effects of oral progesterone. A small number of individuals may experience nausea, mild stomach cramping, or bloating. Consult a clinician if gastrointestinal symptoms persist beyond the initial weeks of therapy.
Normally lasts for:
1–3 hours
Need Help Taking This the Right Way?
Quick, caring advice from pharmacists who know these medications inside out.

This page provides educational information only and is not a substitute for professional medical advice. If you have taken progesterone and melatonin together and have concerns, contact your prescriber or pharmacist for guidance specific to your situation.
What may occur:
What to watch for and discuss with a clinician:
Seek emergency care if any of the following occur:
If you experience any concerning symptoms, contact your prescriber or pharmacist. Do not adjust your medication regimen without professional guidance.
Let’s talk — we focus on your unique needs, with support you can trust.
Progesterone is an endogenous hormone. Per FDA-approved labeling, oral micronized progesterone works in part by modulating GABA-A receptors in the central nervous system, which is associated with its calming and sleep-supportive properties. According to Lexicomp, when taken alongside melatonin, progesterone's CNS effects occur through a distinct receptor pathway from melatonin's action on MT1 and MT2 circadian receptors. These two mechanisms are not generally expected to interact directly in most patients, though additive sedation is theoretically possible and should be considered when evaluating appropriateness for individual patients.
Melatonin is an endogenous hormone involved in circadian rhythm regulation. According to Lexicomp, exogenous melatonin acts primarily on MT1 and MT2 receptors in the suprachiasmatic nucleus to signal the onset of the nighttime period. When used alongside progesterone, melatonin continues its role as a circadian timing signal, functioning through a receptor system separate from progesterone's GABA-modulatory pathway. Per prescribing information, common adverse effects of melatonin receptor agonists include somnolence, which may be additive with progesterone's sedative properties in some individuals.
Talk with us — we’ll walk through your unique situation and support you in feeling confident about your hormone journey.
Does progesterone interact with melatonin?
According to Lexicomp, no clinically significant pharmacokinetic interaction has been identified between progesterone and melatonin. Individual responses vary, however, and both agents carry sedative properties per their respective labeling.
Patients who notice unusual dizziness, prolonged grogginess, or difficulty functioning the next day should contact their prescriber to discuss whether dose timing or dose adjustment is appropriate. A prescriber or pharmacist can provide guidance tailored to individual circumstances.
Does melatonin affect progesterone levels?
Per prescribing information and published literature cited in Lexicomp, melatonin at typical over-the-counter doses acts primarily on circadian rhythm receptors and is not expected to meaningfully alter progesterone levels in women receiving hormone therapy. Some small studies have examined melatonin's relationship to overall hormonal rhythm, but no clinically significant effect on serum progesterone concentrations has been established.
A prescriber should be consulted if there are concerns about potential interactions between melatonin and any prescribed hormone therapy, as individual clinical factors may affect the assessment.
Does progesterone change how melatonin works for sleep?
Per FDA-approved labeling, progesterone has GABA-modulatory properties that may contribute to sedation. According to Lexicomp, no direct pharmacokinetic interaction with melatonin has been established. However, additive CNS effects are theoretically possible when two agents with sedative properties are used concurrently.
Some patients may notice:
Greater ease falling asleep or a more settled feeling at bedtime
Occasional next-morning grogginess, particularly at higher melatonin doses
A prescriber should advise on appropriate dosing and timing based on the individual patient's health profile.
Does melatonin interfere with progesterone therapy?
According to Lexicomp, no clinically significant interaction between melatonin and progesterone has been identified in available interaction databases. The two agents act through distinct receptor systems — melatonin on MT1/MT2 circadian receptors, and progesterone primarily through progesterone receptors and GABA-A modulation — which reduces the likelihood of a direct pharmacodynamic interaction.
That said, both agents are associated with sedative effects per their respective labeling, and the possibility of additive sedation should be discussed with a prescriber. Patients should avoid adding other CNS-depressant agents without clinical guidance, and should contact their prescriber if they experience unusual dizziness, confusion, or persistent next-day sedation.
Ask your prescriber whether a compounded option is appropriate for you. Contact Voshell's Pharmacy for customized compounding support.